Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Immunization (Healthy Volunteers)”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Post-approval studies (Phase 4)Ended earlyNCT02385123
What this trial is testing

Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Study completedNCT03163342
What this trial is testing

Immune Response Following Seasonal Influenza Vaccination

Who this might be right for
Influenza
Altimmune, Inc. 20
Early research (Phase 1)Study completedNCT00261001
What this trial is testing

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

Who this might be right for
Healthy VolunteersHIV Infection
Objectif Recherche Vaccins SIDA 38
Testing effectiveness (Phase 2)Study completedNCT00895544
What this trial is testing

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Who this might be right for
InfluenzaAvian Influenza
Alachua Government Services, Inc. 231
Post-approval studies (Phase 4)Not Yet RecruitingNCT07726862
What this trial is testing

How Healthy Adults Respond to the Nasal Flu Vaccine

Who this might be right for
Mucosal Immune Response to Influenza Vaccination
University of Alabama at Birmingham 20
Early research (Phase 1)Study completedNCT01756950
What this trial is testing

Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses

Who this might be right for
Influenza
Crucell Holland BV 64
Not applicableUnknownNCT05129436
What this trial is testing

Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)

Who this might be right for
Seasonal Influenza Vaccination
University Medicine Greifswald 20
Very early researchStudy completedNCT04484532
What this trial is testing

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Roswell Park Cancer Institute 130
Not applicableLooking for participantsNCT06620185
What this trial is testing

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Who this might be right for
Influenza
Imperial College London 36
Testing effectiveness (Phase 2)Study completedNCT01938352
What this trial is testing

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Who this might be right for
Influenza
Crucell Holland BV 22
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Early research (Phase 1)Study completedNCT01406418
What this trial is testing

Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus

Who this might be right for
Influenza
Crucell Holland BV 64
Post-approval studies (Phase 4)Study completedNCT05050318
What this trial is testing

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 90
Early research (Phase 1)Study completedNCT04451954
What this trial is testing

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

Who this might be right for
Influenza ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 210
Testing effectiveness (Phase 2)Study completedNCT02468115
What this trial is testing

Influenza Challenge Study of VIS410 in Healthy Volunteers

Who this might be right for
Influenza
Visterra, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT01393951
What this trial is testing

Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

Who this might be right for
HealthyImmunogenicity of ASP7374
UMN Pharma Inc. 165
Testing effectiveness (Phase 2)Study completedNCT06361875
What this trial is testing

Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 908
Not applicableStudy completedNCT01191853
What this trial is testing

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

Who this might be right for
Healthy VolunteersInfluenza
National Heart, Lung, and Blood Institute (NHLBI) 203
Early research (Phase 1)Study completedNCT03895385
What this trial is testing

Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects

Who this might be right for
Healthy Volunteers
UCB Biopharma S.P.R.L. 56
Large-scale testing (Phase 3)Study completedNCT04498832
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 2,100
Next Page